Abstract
For a long time human fever has been considered to be a result of an alteration in the body’s thermostat in the hypothalamus, in response to a variety of pyrogenic factors such as bacteria, viruses and fungi. Inflammation, caused by whatever means, has also been thought to cause similar alterations of the thermostat, resulting in fever (Feldberg and Milton 1979). These febrile responses have been considered to be a defence mechanism of the body against such foreign invaders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams SS, Cobb R (1958) A possible basis for the antiinflammatory activity of salicylates and other non-hormonal anti-rheumatic drugs. Nature 181:773–774
Adams SS, Cliffe EE, Lessel B, Nicholson JS (1963) Some biological properties of “ibufenac”, a new antirheumatic drug. Nature 200:271–272
Adams SS, Cliffe EE, Lessel B, Nicholson JS (1967) Some biological properties of 2-(4-iso-butylphenyl)propionic acid. J Pharm Sci 56:1686
Adams SS, Hebborn P, Nicholson JS (1968) Some aspects of the pharmacology of ibufenac, a non-steroidal antiinflammatory agent. J Pharm Pharmacol 20:305–312
Almirante L, Polo L, Mugnaini A et al. (1965) Derivatives of imidazole. I. Synthesis and reactions of imidazo[l,2-a]pyridines with analgesic, antiinflammatory, antipyretic, and anticonvulsant activity. J Med Chem 8:305–311
Almirante L, Polo L, Mugnaini A et al. (1966) Derivatives of imidazole. II. Synthesis and reactions of imidazo[l,2-a]pyrimidines and other bi- and tricyclic imidazo derivatives with analgesic, antiinflammatory, antipyretic, and anticonvulsant activity. J Med Chem 9:29–33
Atkinson DC, Godfrey KE, Jordan BJ, Leach EC, Meek B, Nichols JD, Saville JF (1974) 2-(2,4-Dichlorophenoxy)phenylacetic acid (fenclofenac): one of a novel series of anti-inflammatory compounds with low ulcerogenic potential. J Pharm Pharmacol 26:357–358
Aultz DE, Helsley GC, Hoffman D, McFadden AR, Lassman HB, Wilker JC (1977a) Di-benz[b,e]oxepinalkanoic acids as nonsteroidal anti-inflammatory agents. 1. 6,11-Dihy-dro-ll-oxodibenz[b,e]oxepin-2-acetic acids. J Med Chem 20:66–70
Aultz DE, McFadden AR, Lassman HB (1977b) Dibenz[b,e]oxepinalkanoic acids and non-steroidal antiinflammatory agents. 2. Dihydro-10-oxofuro- and thieno[3,2-c][l]benzox-epin-8-acetic acids. J Med Chem 20:456–458
Barron DI, Copley AR, Vallance DK (1968) Anti-inflammatory and related properties of 4-(p-biphenylyl)-3-hydroxybutyric acid. Br J Pharmacol 33:396–407
Bavin EM, Drain DJ, Seymour DE, Waterhouse PD (1955) Anti-inflammatory compounds. Part I. The activity of a series of new compounds compared with phenylbutazone and cortisone. J Pharm Pharmacol 7:1022–1031
Bavin EM, Macrae FJ, Seymour DE, Waterhouse PD (1952) The analgesic and antipyretic properties of some derivatives of salicylamide. J Pharm Pharmacol 4:872–878
Beaver WT (1965) Mild analgesics: a review of their clinical pharmacology. Am J Med Sci 250:577–604
Beaver WT (1966) Mild analgesics: A review of their clinical pharmacology. Am J Med Sci 251:576–599
Bellasio E, Testa E (1970) Indagine Sulle Ftalazine III (1,2) - Sintesi di nuovi eterocicli diazotati a potenziale attività anti-infiammatoria ottenuti dal tetraidroftalazin-l-one. Farmaco [Sci] 25:305–313
Berger FM (1954) The pharmacological properties of 2-methyl-2-n-propyl-l,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent. J Pharmacol Exp Ther 112:413–423
Berger FM, Keltzkin M, Ludwig BJ, Margolin S, Powell LS (1959) Unusual muscle relaxant and analgesic properties of N-isopropyl-2-methyl-2-propyl-l,3-propanediol dicarbamate (carisoprodol). J Pharmacol Exp Ther 127:66–73
Berger M, Kletzkin M, Ludwig BJ, Margolin S (1960) The history, chemistry and pharmacology of carisoprodol. Ann NY Acad Sci 86:90–107
Berger FM, Bates HM, Diamantis W, Kletzkin M, Plekss OJ, Sofia RD, Spencer HJ (1973) The pharmacological properties of seclazone (7-chloro-33a-dihydro-2H,9H-isox- azolo[3,2-b][l,3]benzoxazin-9-one). A new anti-inflammatory agent. Pharmacology 9:164–176
Bianchi C, Lumanchi B, Marazzi-Uberti E (1972) Pharmacological investigations of 4-prenyl-l,2-diphenyl-3,5-pyrazolidinedione (DA 2370). Part 1: Antiinflammatory, analgesic and antipyretic properties. Arzneim Forsch 22:183–191
Boots Pure Drug Company Ltd (1967) South African Patent 62/294
Borovsky MP (1960) Antipyretic activity of acetylsalicyclic acid and salicylamide suspension in pediatrics. A comparative clinical evaluation in two hundred six cases. Am J Dis Child 100:47/23–54/30
Brown K, Cavalla JF, Green D, Wilson AB (1968) Diaryloxazole and diarylthiazo- lealkanoic acids: Two novel series of non-steroidal anti-inflammatory agents. Nature 219:164
Brown K, Cater DP, Cavalla JF, Green D, Newberry RA, Wilson AB (1974) Nonsteroidal antiinflammatory agents. I. 2,4-Diphenylthiazole-5-acetic acid and related compounds. J Med Chem 17:1177–1181
Buckler JW, Adams SS (1968) The phenylalkanoic acids. Laboratory and clinical studies. Med Proc 14:574–578
Buckler RT, Hayao S, Lorenzetti OJ, Sancilio LF, Hartzler HE, Strycker WG (1970) Synthesis and antiinflammatory activity of some aryltetrazolylalkanoic acids. J Med Chem 13:725–729
Buller RH, Miya TS, Carr CJ (1957) The comparative antipyretic activity of acetylsalicylic acid and salicylamide in fever-induced rats. J Pharm Pharmacol 9:128–133
Buss CE (1876) On the antipyretic action of cresotinic acid. Klin Wochenschr 13:445
Buttinoni A, Cuttica A, Franceschini J, Mandelli V, Orsini G, Passerini N, Turba C, Tommasini R (1973) Pharmacological study on a new analgesic-antiinflammatory drug: α- [4-(l-oxo-2-iso-indolinyl)-phenyl]-propionic acid or K4277. Arzneim Forsch 23:1100- 1107
Buu-Höi NP, Lambelin G, Gillet C, Lepoivre C, Thiriaux J, Mees G (1966) Arylacethydrox- amic acids: a new class of potent non-steroid anti-inflammatory and analgesic substances. Nature 211:752
Buu-Höi NP, Lambelin G, Gillet C, Roba J, Staquet M (1969) 4-Allyloxy-3-chlorophenyl- acetic acid, a new type of analgesic, antipyretic and antiphlogistic drug. Naturwissen- schaften 56:330–331
Buu-Höi NP, Gillet CL, Lambelin GE, Roba JL, Thiriaux JE (1970) Synthesis and pharmacological properties of substituted cinnamohydroxamic acids. J Med Chem 13:211–213
Cahn A, Hepp P (1886) Das Anpifebrin, ein neues Fiebermittel. Centralbl Klin Med 7:561- 564
Campbell WC (1971) Anti-inflammatory and analgesic properties of thiabendazole. JAMA 216:2143
Caprino L, Barrelli F, Falchetti R (1973) Pharmacological research on 4,5-diphenyl-2-tò(2- hydroxyethyl)aminoxazol(Ditazol), a new synthetic oxazole derivative as an antiinflammatory agent. Arzneim Forsch 23:1272–1277
Carson JR, Wong S (1973) 5-Benzoyl-l-methylpyrrole-2-acetic acids as anti-inflammatory agents. 2. J Med Chem 16:172–174
Carson JR, McKinstry DN, Wong S (1971) 5-Benzoyl-l-methylpyrrole-2-acetic acids as antiinflammatory agents. J Med Chem 14:646–647
Casadio S, Pala G, Marazzi-Uberti E, Lumachi B, Crescenzi E, Donetti A, Mantegani A, Bianchi C (1972) Terpene compounds as drugs. X. 4-Prenyl-l,2-diphenyl-3,5- pyrazolidinedione (DA 2,370): a new antiinflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones. Arzneim Forsch 22:171–174
Casagrande C, Invernizzi A, Ferrini R, Miragoli G (1971) Indolizine analogues of in- domethacin. Farmaco [Sci] 26:1059–1073
Cashin CH, Dawson W, Kitchen EA (1977) The pharmacology of benoxaprofen (2-[4- chlorophenyl]-a-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol 29:330–336
Clark WG (1979) Mechanisms of antipyretic action. Gen Pharmacol 10:71–77 Clark WG, Coldwell BA (1972) Competitive antagonism of leukocytic pyrogen by sodium salicylate and acetaminophen. Proc Soc Exp Biol Med 141:669–672
Clark WG, Cumby HR (1975) The antipyretic effect of indomethacin. J Physiol (Lond) 248:625–638
Clark RL, Pessolano AA, Witzel B, Lanza T, Shen TY, Van Arman CG, Risley EA (1978) 2-(Substituted phenyl)oxazolo[4,5-b]pyridines and 2-(substituted phenyl)oxazolo[5,4- b]pyridines as non-acidic antiinflammatory agents. J Med Chem 21:1158–1165
Clarke NE, Mosher RE, Clarke CN (1953) Phenolic compounds in the treatment of rheumatic fever. I. A study of gentisic acid derivatives. Circulation 7:247–257
Clarke NE, Clarke CN, Mosher RE (1958) Phenolic compounds in chemotherapy of rheumatic fever. Am J Med Sci 235:7–22
Clémence F, LeMartret O, Fournex R, Plassard G, Dagnaux M (1974) Thiophene derivatives with antiinflammatory and analgesic activities. Eur J Med Chem 9:390–396
Colgan MT, Mintz AA (1957) The comparative antipyretic effect of N-acetyl-p-amino- phenol and acetylsalicylic acid. J Pediatr 50:552–555
Collier HOJ, Chesher GB (1956) Antipyretic and analgesic properties of two hydroxyiso- phthalic acids. Br J Pharmacol 11:20–26
Colot M, Van Damme M, Dirks M, Beersaerts J, Deridder G, Charlier R (1973) Recherches dans la série des indoles. II. Propriétés anti-inflammatories et anti-arthritiques de l’(iso- propyl-2-indolyl)-3-pyridyl-3 cétone. Therapie 28:775–798
Colot M, Van Damme M, Dirks M, Beersaerts J, Charlier R (1974) Antiinflammatory and antiarthritic properties of 5-chloro-3-methylbenz[b]thiofen-2-acetic acid. Arch Int Phar- macodyn Ther 208:328–342
Committee of Revision (1979) Pyrogen test. In: The United States Pharmacopeia, Twentieth Revision, Mack, Easton, Pa, pp 902–903
Coombs R, Houlihan WJ, Nadelson J, Takesue EI (1971) Synthesis and anti-inflammatory activity of tert-aminomethylbenzophenones. J Med Chem 14:1072–1074
Coombs RV, Danna RP, Denzer M et al. (1973) Synthesis and anti-inflammatory activity of l-alkyl-4-aryl-2(lH)-quinazolinones and quinazolinethiones. J Med Chem 16:1237–1245
Cranston WI, Rawlins MD (1972) Effects of intracerebral micro-injection of sodium salicylate on temperature regulation in the rabbit. J Physiol (Lond) 222:257–266
Cranston WI, Luff RH, Rawlins MD, Wright VA (1971 a) The influence of the duration of experimental fever on salicylate antipyresis in the rabbit. Br J Pharmacol 41:344–351
Cranston WI, Luff RH, Rawlins MD (1971b) Antipyretic properties of some metabolic and structural analogues of sodium salicylate. J Physiol (Lond) 216:81 P-82P
Cranston WI, Hellon RF, Mitchell D (1975) A dissociation between fever and PG concentration in the cerebrospinal fluid. J Physiol (Lond) 253:583–592
Cranston WI, Duff GW, Hellon RF, Mitchell D (1976) Effect of a PG antagonist on the pyrexia caused by PGE2 and leucocyte pyrogen in rabbits. J Physiol (Lond) 256:120- 121P
Davies JE, Kellett DN, Pennington JC (1976) The anti-inflammatory and analgesic effects of Norvedan, a novel non-steroidal agent. Arch Int Pharmacodyn Ther 221:274–282
Demerson CA, Humber LG, Dobson TA, Martel RR (1975) Chemistry and antiinflammatory activities of prodolic acid and related l,3,4,9-tetrahydropyrano[3,4–6]indole-l- alkanoic acids. 1. J Med Chem 18:189–191
DiPasquale G, Rassaert CL, Richter RS, Tripp LV (1973) The antiinflammatory effects of 4-hydroxy-2-methyl-3-phenylcarbamoyl-2 H-1,2-benzothiazine-1,1 -dioxide (W 7477). Arch Int Pharmacodyn Ther 203:92–100
Dobner J (1930) Amatin, ein neues, die Diaphorese nicht anregendes Antipyretikum. MMW 77:1103–1104
Domenjoz R (1960) The pharmacology of phenylbutazone analogues. Ann NY Acad Sei 86:263–291
Dorfman RI (1975) Chemistry and pharmacology of naproxen. Arzneim Forsch 25:278–281
Douglas JF, Edelson J, Ludwig BJ (1972) Metabolic fate of 7-chloro-3,3a-dihydro-2H,9H isoxazolo[3,2-b][l,3]benzoxazin-9-one W-2354. Fed Proc 31:578
Draper MD, Petracek FJ, Klohs MW, McClure DA, Levy L, Re ON (1972) p-Fluoro- phenyl-4-(p-fluorphenyl)-4-hydroxy-l-methyl-3-piperidyl ketone (Flazalone): A novel non-steroidal antiinflammatory agent. Arzneim Forsch 22:1803
Dreser H (1899) Pharmakologisches über Aspirin (Acetylsalicylsäure). Pfluegers Arch Ges Physiol 76:306–318
Dunwell DW, Evans D, Hicks TA, Cashin CH, Kitchen A (1975) 2-Aryl-5-benzoxazo- lealkanoic acid derivatives with notable antiinflammatory activity. J Med Chem 18:53–58
Durant GJ, Smith GM, Spickett RGW (1965) Nonsteroidal antiinflammatory agents. Some arylacetic acids. J Med Chem 8:598–603
Edelson J, Douglas JF, Ludwig BJ (1972) The absorption and distribution of 7-chloro-3,3a- dihydro-2H,9H-isoxazolo[3,2-b][l,3]benzoxazin-9-one, W-2354. Fed Proc 31:578
Ellis KO, Castellion AW, Honkomp LJ, Wessels FJ, Carpenter JF, Halliday RP (1973) Dantrolene, a direct acting skeletal muscle relaxant. J Pharm Sei 62:948–951
Emele JF, Shanaman JE (1967) Analgesic activity of namoxyrate (2-[4-biphenylyl]butyric acid 2-dimethylaminoethanol salt). Arch Int Pharmacodyn Ther 170:99–107
Feldberg W, Gupta KP (1973) Pyrogen fever and prostaglandin activity in cerebrospinal fluid. J Physiol (Lond) 228:41–53
Feldberg W, Milton AS (1979) Prostaglandins and body temperature. In: Vane JR, Ferreira SH (eds) Antiinflammatory drugs. (Handbook of experimental pharmacology, vol 50/I.) Springer, Berlin Heidelberg New York, pp 617–656
Feldberg W, Gupta KP, Milton AS, Wendlandt S (1973) Effects of pyrogen and antipyretics on prostaglandin activity in cisternal CSF of unaneasthetized cats. J Physiol (Lond) 234:279–303
Ferreira SH, Vane JR (1974) New aspects of the mode of action of nonsteroidal anti-inflammatory drugs. Ann Rev Pharmacol 14:57–73
Ferris JP, Boyce CB, Briner RC, Douglas B, Kirkpatrick JL, Weisbach JA (1966) Lythraceae alkaloids. Structure and stereochemistry of the major alkaloids of Decodon and Heimia. Tetrahedron Lett 3641–3649
Fleming JS, Bierwagen ME, Pircio AW, Pindell MH (1969) A new antiinflammatory agent, l-(4-chlorobenzoyl)-3-(5-tetrazolylmethyl)indole (BL-R743). Arch Int Pharmacodyn Ther 178:423–436
Flower RJ, Vane JR (1972) Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol). Nature New Biol 240:410–411
Fujimura H (1973) Pharmacological studies on some new quinazoline derivatives. (1). Antiinflammatory and some other properties. Jpn J Pharmacol [Suppl] 23:190
Fujimura H, Tsurumi K, Nozaki M, Hiramatsu Y, Tamura Y, Shimazawa T (1974) Pharmacological studies on H27 and H88, the new quinazoline-2,4-dione derivatives. I. Antiinflammatory, analgesic, and antipyretic activities. Nippon Yakurigaku Zasshi 70:673–695
Gibson KH (1977) Prostaglandins, thromboxanes, PGX: biosynthetic products from arachidonic acid. Chem Soc Rev 6:489–510
Glenn EM, Bowman BJ, Kooyers W, Koslowske T, Myers ML (1967) The pharmacology of 2,3-te-(p-methoxyphenyl)indole (indoxole). J Pharmacol Exp Ther 155:157–166
Gross M, Greenberg LA (1948) The salicylates. A critical bibliographic review. Hillhouse, New Haven, pp 1–7 Gruber CM Jr (1974) Antipyresis with fenprofen. J Clin Pharmacol 14:215–218
Gruber CM Jr, Collins T (1972) Antipyretic effect of fenprofen. J Med Clin Exp 3:242–248
Gund P, Shen TY (1977) A model for the prostaglandin synthetase cyclooxygenation site and its inhibition by antiinflammatory arylacetic acids. J Med Chem 20:1146–1152
Hannah J, Ruyle WV, Kelly K, Matzuk A, Holtz WJ, Witzel BE, Winter CA, Silber RH, Shen TY (1970) Flufenisal - A new salicylate analog. Abstracts Joint Conference of the Chemical Institute of Canada and the American Chemical Society. Toronto, Canada, May 1970. No MEDI 18
Hannah J, Ruyle WV, Jones H, Matzuk AR, Kelly KW, Witzel BE, Holtz WJ, Houser RA, Shen TY, Sarett LH, Lotti VJ, Risley EA, Van Arman CG, Winter CA (1978) Novel analgesic-antiinflammatory salicylates. J Med Chem 21:1093–1099
Harrison GG (1975) Control of the malignant hyperpyretic syndrome in MHS swine by dantrolene sodium. Br J Anaesth 47:62–65
Harrison IT, Lewis B, Nelson P, Rooks W, Roszkowski A, Tomolonis A, Fried JH (1970) Nonsteroidal antiinflammatory agents. I. 6-Substituted 2-naphthylacetic acids. J Med Chem 13:203–205
Harvey CA, Milton AS, Straughan DW (1975) Prostaglandin levels in cerebral spinal fluid of rabbits and the effects of bacterial pyrogen and antipyretic drugs. J Physiol (Lond) 248:26–27 P
Hepworth W, Newbould BB, Platt DS, Stacy GJ (1969) 2-(4-Chlorophenyl) thiazol-4- ylacetic acid (“Myalex”): A new compound with anti-inflammatory, analgesic and antipyretic activity. Nature Lond 221:582–583
Hoyland JR, Kier LB (1972) Preferred conformation of prostaglandin E1. J Med Chem 15:84–86
Hucker HB, Stauffer SC, White SD et al. (1973) Physiologie disposition and metabolic fate of a new antiinflammatory agent, cw-5-fluoro-2-methyl-1 -[p-methylsulfmyl)benzylin- denyl]indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metab Dispos 1:721–736
Iizuka Y, Tanaka K (1972) Antiinflammatory effect of bimetopyrol. II. Suppressive effect on adjuvant arthritis in rats. J Pharm Soc Jpn 92:11–18
Janssen PAJ (1975) Suprofen (R 25061), a new potent inhibitor of prostaglandin biosynthesis. Arzneim Forsch 25:1495 Jones CJ (1976) The pharmacology and pharmacokinetics of azapropazone - a review. Curr Med Res Opinion 4:3–15
Jones H, Fordice MW, Greenwald RB et al. (1978) Synthetic and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids. J Med Chem 21:1100–1104
Juby PF, Hudyma TW (1969) Preparation and antiinflammatory properties of some 1-substituted 3-(5-tetrazoylmethyl)indoles and homologs. J Med Chem 12:396–400
Juby PF, Goodwin WR, Hudyma TW, Partyka RA (1972 a) Antiinflammatory activity of some indan-l-carboxylic acids and related compounds. J Med Chem 15:1297–1306
Juby PF, Goodwin WR, Hudyma TW, Partyka RA (1972 b) Antiinflammatory activity and structure-activity relationship of some 1,2,3,4-tetrahydro-1-naphthoic acids and related compounds. J Med Chem 15:1306–1310
Julou L, Guyonnet J-C (1967) Propriétés anti-inflammatories de l’acide (méthyl-10-phéno- thiazinyl-2) acétique (16091 R.P.). CR Acad Sei [D] Paris 265:1007–1010
Julou L, Guyonnet J-C, Ducrot R, Bardone MC, Detaille GY, Laffargue B (1969) General pharmacological properties of metiazinic acid (16091 R.P.). Arzneim Forsch 19:1198- 1206
Julou L, Guyonnet J-C, Ducrot R, Garret C, Bardone MC, Maignan G, Pasquet J (1971) Study of the pharmacological properties of a new anti-inflammatory drug: 2-(3-benzoyl- phenyl)-propionic acid (19583 R.P.). J Pharmacol (Paris) 2:259–286
Kadatz R (1957) Pharmakologische Eigenschaften des 2-(0-Chloroethyl)-2,3-dihydro-4- oxo-(benzo-l,3-oxazin), eines neuen Antiphlogisticum. Arzneim Forsch 7:651–653
Kadin SB, Wiseman BH (1969) Dioxoisoquinoline-4-carboxanilides - a new class of nonsteroidal anti-inflammatory agents. Nature Lond 222:275–276
Kaltenbronn JS (1973) 4- and 5-Aryl-l-naphthaleneacetic acids as antiinflammatory agents. J Med Chem 16:490–493
Kaplan HR, Wolke RE, Malone MH (1967) Anti-inflammatory evaluation of cryogenine. J Pharm Sei 56:1385–1392
Kawai K, Kuzuna S, Morimoto S, Ishii H, Matsumoto N (1971) Antiinflammatory, analgesic, and antipyretic activities of 6-chloro-5-cyclohexylinden-l-carboxylic acid (TAI- 284). Jpn J Pharmacol 21:621–639
Knoll J, Gyires K, Meszaros Z (1979) l,6-Dimethyl-4-oxo-l,6,7,8,9a-hexahydro-4H-pyri- do[l,2-fl]pyrimidine-3-carboxamide (Chinoin-127), a potent non-narcotic analgesic and antiinflammatory agent. Arzneim Forsch 29:766–773
Knorr L (1883) Entwirkung von Acetessigester auf Phenylhydrazine. Ber 16:2597–2599
Knorr L (1884) Ueber die Constitution des Chinizin Derivatives. Ber 17:2032–2049
Kobayashi S, Takagi H (1968) Pharmacological studies of a new antiinflammatory compound, 2-phenyl-6-dimethylamino-6H-cyclohept oxazole. Arzneim Forsch 18:1352- 1354
Koch-Weser J (1976 Acetaminophen. N Eng J Med 295:1297–1300
Komatsu T, Awata H, Sakai Y, Inukai T, Yamamoto M, Inaba S, Yamamoto H (1972) Novel quinazoline derivatives. I. Synthesis and preliminary pharmacological evaluation of an anti-inflammatory agent, SL-573. Arzneim Forsch 22:1958–1962
Lambelin G, Büu-Hoi NP, Brouihet H, Gautier M, Gillet C, Roba J, Thiriaux J (1968) Relationships between structure and four types of pharmacologic activity in arylacethydrox- amic acids. Arzneim Forsch 18:1404–1408
Lambelin G, Roba J, Gillet C, Büu-Hoi NP (1970) Pharmacology of a new analgesic, antipyretic and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid. Arzneim Forsch 20:610–618
Lang SA Jr, Johnson BD, Cohen E, Sloboda AE, Greenblatt E (1976) Aryl-s-tetrazines with antiinflammatory activity. J Med Chem 19:1404–1409
Lassman HB, Wilker JC, Anderson VB, Agnew MN, Allen RC, Novick WJ Jr (1978) Fendosal (HP 129): A potent antiinflammatory and analgesic compound. Agents Actions 8:209–217
Lee EB, Shin KH, Woo WS (1968) Synthesis and pharmacology of p-methoxycinnamic acid derivates. J Med Chem 11:1262–1263
Levy L, McClure D (1976) The pharmacology of flazalone: A new class of anti-inflammatory agent. J Pharmacol Exp Ther 198:473–480
Lin MT, Chai CY (1972) The antipyretic effect of sodium acetylsalicylate on pyrogen-induced fever in rabbits. J Pharmacol Exp Ther 180:603–609
Lindner E (1973) The antipyretic action of pyrazolones, derivatives of phenacetin and other new substances. In: Schönbaum E, Lomax P (eds) The pharmacology of thermoregulation. Symposium, San Francisco, 1972. Karger, Basel, pp 325–344
Lombardino JG (1974) Enolic acids with antiinflammatory activity. In: Scherrer AA, Whitehouse MW (eds) Antiinflammatory agents, chemistry, and pharmacology, vol 1. Academic Press, New York, pp 129–157
Lombardino JG, Wiseman EH (1971) Antiinflammatory 3,4-dihydro-2-alkyl-3-oxo-2H-l,2-benzothiazine-4-carboxamide 1,1-dioxides. J Med Chem 14:973–977
Lombardino JG, Wiseman EH (1972) Sudoxicam and related iV-heterocyclic carboxamides of 4-hydroxy-2H-l,2-benzothiazine-1,1-dioxide. Potent nonsteroidal antiinflammatory agents. J Med Chem 15:848–849
Lombardino JG, Wiseman EH, McLamore WM (1971) Synthesis and antiinflammatory activity of some 3-carboxamides of 2-alkyl-4-hydroxy-2H-l,2-benzothiazine-1,1-dioxide. J Med Chem 14:1171–1175
Lombardino JG, Wiseman EH, Chiani J (1973) Potent antiinflammatory N-heterocyclic 3- carboxamides of 4-hydroxy-2-methyl-2H-l,2-benzothiazine-1,1-dioxide. J Med Chem 16:493–496
Lombardino JC, Otterness IG, Wiseman EH (1975) Acidic antiinflammatory agents - correlations of some physical, pharmacological and clinical data. Arzneim Forsch 25:1629–1635
Loux J J, DePalma PD, Yankell SL (1972) Antipyretic testing of aspirin in rats. Toxicol Appl Pharmacol 22:672–675
Marazzi-Uberti E, Turba C (1966) a-isopropyl-a-(2-dimethylaminoethyl)-l-naphthylaceta- mide (naphthypramide, DA 992): A new antiinflammatory agent. I. Antiinflammatory activity and acute toxicity. Arch Int Pharmacodyn Ther 162:378–396
Marazzi-Uberti E, Turba C, Erba G (1966) a-isopropyl-a-(2-dimethylaminoethyl)-l-naphthylacetamide (naphthypramide, DA 992): A new antiinflammatory agent. II. Antipyretic, analgesic and C.N.S. depressant activity. Arch Int Pharmacodyn Ther 162:398–412
Marchetti E, Mattalia G, Rosnati V (1968) A new class of analgetic-antiinflammatory agents. 2-Substituted 4,5-diphenyloxazoles. J Med Chem 11:1092–1093
Marmo E, Rossi F, DiNola R, Cazzola F (1974) Experimentation of an anti-reactional, antalgic, and antipyretic drug (2-phenyl-4-chlorophenylthiazol-5-yl acetic acid). Gazz Med Ital 133:337–344
Martel RR, Klicius J (1976) Antiinflammatory and analgesic properties of etodolic acid in rats. Can J Physiol Pharmacol 54:245–248
Martel RR, Klicius J, Herr F (1974a) Investigation of 1,3,4,9-tetrahydro-l-propyl- pyrano[3,4–6]indole-l-acetic acid (prodolic acid), a new nonsteroidal anti-inflammatory agent, in rats. Agents Actions 4:370–376
Martel RR, Rochefort JG, Klicius J, Dobson TA (1974 b) Antiinflammatory properties of furobufen. Can J Physiol Pharmacol 52:669–673
Messer M, Farge D (1967) Synthèse des acides (méthyl-10-phénothiazinyl) acétiques. C R Acad Sci [C] 265:758–761
Messer PM, Farge D, Guyonnet J-C, Jeanmart C, Julou L (1969) Acidic derivatives of phenothiazin. Arzneim Forsch 19:1193–1198
Meyer K, Ragan C (1948) The antirheumatic effect of sodium gentisate. Science 108:281
Mielke CH Jr, Heiden D, Britten AF, Ramos J, Flavell P (1976) Hemostatis, antipyretics, and mild analgesics. Acetominophen vs. aspirin. JAMA 235:613–616
Milton AS, Wendlandt S (1965) The effect of 4-acetamidophenol in reducing fever produced by the intracerebral injection of 5-hydroxytryptamine and pyrogen in the conscious cat. Br J Pharmacol 34:215P-216P
Milton AS, Wendlandt S (1970) A possible role for prostaglandin E1 as a modulator for temperature regulation in the central nervous system of the cat. J Physiol (Lond) 207:76–77 P
Minakami H, Takagi H, Kobayashi S (1964) Pharmacological studies of a new analgesic and antiinflammatory agent, l-benzylcycloheptimidazol-2(lH)-one, (RCH-314). Life Sci 3:305–314
Naito T, Yoshikawa T, Kitahara S, Aoki N (1969) Studies on pyrimidinylpyrazoles. I. Syntheses of 1- and 2-pyrimidinyl-3-methylpyrazolin-5-one derivatives. Chem Pharm Bull (Tokyo) 17:1467–1478
Nakamura H, Kadokawa T, Nakatsuji K, Nakamura K (1970) Pharmacological studies of a new antiinflammatory drug, l-phenylsulfonyl-5,5-diphenylhydantoin (PG-796) in experimental animals. I. Antiinflammatory, analgesic and antipyretic activity. Arzneim Forsch 20:1032–1046
Nakanishi M, Imamura H, Maruyama Y, Hoshino H (1970 a) Studies on antiinflammatory agents. I. Some biological activities of thienopyridine derivatives. Yakugaku Zasshi 90:272–276
Nakanishi M, Imamura H, Maruyama Y (1970b) Studies on antiinflammatory agents. II. Analgesic and anti-edematous activities of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7- tetrahydrothieno[2,3-c]pyridine.Yakugaku Zasshi 90:277–283
Nakanishi M, Imamura H, Maruyama Y (1970c) Studies on antiinflammatory agents. III. Effect of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydro[2,3-c]pyridine (Y- 3642) on pyretic reaction, vascular permeability and granuloma formation in experimental animals. Yakugaku Zasshi 90:284–290
Nakanishi M, Imamura H, Maruyama Y (1970d) Pharmacological investigations of 2- amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine. Part I. Arzneim Forsch 20:998–1003
Nakanishi M, Imamura H, Ikegami K, Goto K (1970e) Pharmacological investigations of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrathieno[2,3-c]pyridine. Part II. Arzneim Forsch 20:1004–1009
Nannini G, Giraldi PN, Malgora G et al. (1973) New analgesic-antiinflammatory drugs. Arzneim Forsch 23:1090–1100
Newbould BB (1969) The pharmacology of fenclozic acid (2-(4-chlorophenyl)-thiazol-4-glacetic acid; I.C.I. 54,450; “Myalex”); a new compound with anti-inflammatory, analgesic, and antipyretic activity. Br J Pharmacol 35:487–497
Nickander RC, Kraay RJ, Marshall WS (1971) Antiinflammatory and analgesic effects of fenoprofen. Fed Proc 30:563
Niemegeers CJE, Verbruggen FJ, Janssen PAJ (1964) Effect of various drugs on carrageenin-induced oedema in the rat hind paw. J Pharm Pharmacol 16:810–816
Niemegeers CJE, Lenaerts FM, Janssen PAJ (1975) The antipyretic effect of suprofen in rats with yeast-induced fever. Arzneim Forsch 25:1519–1524
Noguchi S, Kishimoto S, Minamida I, Obayashi M, Kawakita K (1971) 6-Chloro-5-cyclohexylinden-l-carboxylic acid (TAI-284), a new antiinflammatory agent. Chem Pharm Bull (Tokyo) 19:646–648
Nuss GW, Smyth RD, Breder CH, Hitchings MJ, Mir GN, Reavey-Cantwell NH (1976) The antiphlogistic, antinociceptive and antipyretic properties of fenclorac. Agents Actions 6:735–747
Olson DR, Wheeler WJ, Wells JN (1974) Rigid analogs of indomethacin. J Med Chem 17:167–171
Ory M (1949) Premiers essais thérapeutiques de l’acide gentisique dans les affections rheumatismales. Brüx Med 29:1401
Oshima Y, Akimoto T, Tsukada W, Yamasaki T, Yamaguchi K, Kojima H (1969) Studies on pyrimidinylpyrazoles. IV. Pharmacological activities of l-(4-methoxy-6-methyl-2-pyrimidinyl)-3-methyl-5-methoxypyrazole and its related compounds. Chem Pharm Bull (Tokyo) 17:1492–1497
Pala G, Casadio S, Bruzzese T, Crescenzi E, Marazzi-Uberti E (1965) Structure-activity relationships in antiinflammatory and analgesic compounds chemically related to a-iso-propyl-2-(2-dimethylaminoethyl)-l-naphthylacetamide. J Med Chem 8:698–700
Pala G, Bruzzese T, Marrazi-Uberti E, Coppi G (1966) Synthesis and pharmacological evaluation of a-substituted 1-naphthylacetic acids. J Med Chem 9:603–605
Phillip-Dormston WK, Siegert R (1974) Prostaglandins of the E and F series in rabbit cerebrospinal fluid during fever induced by Newcastle disease virus, E. Coli-endotoxin or endogenous pyrogens. Med Microbiol Immunol (Berl) 159:279–284
Pircio AW, Bierwagen ME, Strife WE, Nicolosi WD (1972) Pharmacology of a new nonsteroidal antiinflammatory agent 5-cyclohexylindan-l-carboxylic acid. Arch Int Pharmacodyn Ther 199:151–163
Pittman QJ, Veable WL, Cooper KE (1975) Temperature responses of lambs after centrally injected PGs and pyrogens. Am J Physiol 228:1034–1038
Plazzo G, Car si G, Baiocchi L, Silvestrini B (1966) Synthesis and pharmacological properties of 1-substituted 3-dimethylaminoalkoxy-lH -indazoles. J Med Chem 9:38–41
Randall LO, Baruth H (1976) Analgesic and antiinflammatory activity of 6-chloro-a-methyl-carbazole-2-acetic acid (C-5720). Arch Int Pharmacodyn Ther 220:94–114
Reid J, Watson RD, Cochran JB, Sproull DH (1951) Sodium y-resorcylate in rheumatic fever. Br Med J 2:321–325
Reisner DB, Ludwig BJ, Stiefel FJ, Gister S, Meyer M, Powell LS, Sofia RD (1977 a) Synthesis and antiinflammatory activity of 3,3a-dihydro-2H,9H -isoxazolo[3,2–6][l,3]-benzoxazin-9-ones and related compounds. Arzneim Forsch 27:760–766
Reisner DB, Ludwig BJ, Simon E, Dejneka T (1977 b) Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2–6]quinazolin-9-one (W-2429). Arzneim Forsch 27:766–770
Robichaud RC, Malone MH, Schwarting AE (1964) Pharmacodynamics of cryogenine, an alkaloid isolated from Heimia salicifolia link and otto. Part I. Arch Int Pharmacodyn Ther 150:220–232
Rohte O (1971) Tierpharmakologische Versuche mit Leo 1028, einer neuen Substanz mit antiphlogistischen, analgetischen und antipyretischen Eigenschaften. Acta Pharmacol Toxicol [Suppl 4] 29:47
Rooks WH II, Tomolonis AJ, Maloney PJ, Wallach MB, Schuler ME (1979) The analgesic and antiinflammatory profile of (±)-5-benzoyl-l,2-dihydro-3if-pyrrolo[l,2-a]pyrrole- 1-carboxylic acid (DPP). Fed Proc 38:1115
Roszkowski AP, Rooks WH II, Tomolonis AJ, Miller LM (1971) Antiinflammatory and analgesic properties of d-2-(6’-methoxy-2’-naphthyl)-propionic acid (Naproxen). J Pharmacol Exp Ther 179:114–123
Sato M, Tanizawa H, Fukuda T, Yuizono T (1979) Pharmacological investigations of 4- alkoxy-2-methyl-5-morpholino-3(2H)-pyridazinone derivatives. Jpn J Pharmacol 29:303–306
Schaaf TK (1977) Modulation of the arachidonic acid cascade. In: Clarke FH (ed) Annual reports in medicinal chemistry, vol 12. Academic Press, New York, pp 182–190
Schaefer LE, Rashkoff IA, Megibow RS (1950) Sodium gentisate in the treatment of acute rheumatic fever. Circulation 2:265–270
Scherrer RA (1974) Introduction to the chemistry of antiinflammatory and antiarthritic agents. In: Scherrer RA, Whitehouse MW (eds) Antiinflammatory agents, chemistry and pharmacology, vol 1. Academic Press, New York, pp 29–43
Scherrer RA, Winder CV, Short FW (1964) The antiinflammatory TV-arylanthranilic acids. National Medicinal Chemistry Symposium (ACS Medicinal Chem Div) Abstract Proceedings, pp 11a-11i
Schiatti P, Selva D, Arrigoni-Martelli E, Lerner LJ, Diena A, Sardi A, Maffii G (1974) Antiinflammatory activity and other pharmacological properties of phthalazino-[2,3–6]- phthalazine-5,12(7 H, 14 H)-dione (Diftalone). Arzneim Forsch 24:2003–2009
Schoener EP, Wang SC (1975) Observations on the central mechanism of acetylsalicylate antipyresis. Life Sei 17:1063–1068
Senda S, Izumi H, Fujimura H (1967) Über Uracil-Derivate und verwandte Verbindungen. Arzneim Forsch 17:1519–1523
Senda S, Hirota K, Banno K (1972) Pyrimidine derivatives and related compounds. 15. Synthesis and analgetic and antiinflammatory activities of 1,3-substituted 5-amino-6-methyluracil derivatives. J Med Chem 15:471–476
Shen TY (1965) Synthesis and biological activity of some indomethacin analogs. Excerpta mMed Int Congr Ser 82:13–20
Shen TY (1967 a) Anti-inflammatory agents. In: Rabinowitz JL, Myerson RM (eds) Topics in medicinal chemistry, vol 1. Interscience Publisher, New York, pp 29–78
Shen TY (1967 b) Antiinflammatory arylacetic acid derivatives. Chim Ther 2:459–461
Shen TY, Windholz TB, Rosegay A et al. (1963) Non-steroid antiinflammatory agents. J Am Chem Soc 85:488–489
Shen TY, Ham EA, Cirillo VJ, Zanetti M (1974) Structure-activity relationship of certain prostaglandin synthetase inhibitors. In: Robinson HJ, Vane JR (eds) Prostaglandin synthetase inhibitors. Raven, New York, pp 19–31
Shen TY, Winter CA (1977) Clinical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 12:89–246
Shibata Y (1977) Antiinflammatory, analgesic and other related actions of 4’-chloro-5-methoxy-3-biphenylacetic acid (DKA-9). Arzneim Forsch 27:2299–2308
Silvestrini B, Gorau A, Pozzatti C, Cioli V (1966) Pharmacological research on benzydamine - a new analgesic-antiinflammatory drug. Arzneim Forsch 16:59–63
Similä S, Kouvalainen K, Keinänen S (1977) Oral antipyretic therapy. Evaluation of mefenamic acid (short communication). Arzneim Forsch 27:687–688
Snyder HR, Davis CS, Bickerton RK, Halliday RP (1967) l-[(5-arylfurfurylidene)amino]hydantoins. A new class of muscle relaxants. J Med Chem 10:807–810
Sofia RD, Diamantis W, Gordon R et al. (1974) Pharmacology of a new nonsteroidal antiinflammatory agent, 7-chloro-3,3a-dihydro-2-methyl-2H,9H -isoxazolo[3,2-b][1,3]benzoxazin-9-one (W-2395). Eur J Pharmacol 26:51–62
Sofia RD, Diamantis W, Ludig BJ (1977) Pharmacological properties of 2,3-dihydro-9H- isoxazolo[3,2–2-β]quinazolin-9-one (W-2429). Arzneim Forsch 27:770–782
Soma N, Nakazawa J, Watanabe T, Sato Y, Sunagawa G (1967) Studies on seven-mem- bered ring compounds. XXIII. Reaction of tropylium ions having fused heterocyclic system with various amines. Chem Pharm Bull (Tokyo) 15:627–633
Stenzl H, Staub A, Simon C, Baumann W (1950) 3-amino-5-pyrazolones. Helv Chem Acta 33:1183–1194
Stockman R (1912) The therapeutic action of cresotinic acid. J Pharmacol Exp Ther 4:97–108
Stone CA, Van Arman CG, Lotti VJ et al. (1977) Pharmacology and toxicology of diflunisal. Br J Clin Pharmacol 4:19S-29S
Stone E (1763) An account of the success of the bark of the willow - the cure of agues. Philos Trans R Soc Lond 53:195–200
Swingle KF, Scherrer RA, Grant TJ (1975) Antiinflammatory activity of a-methyl-3- phenyl-7-benzofuranacetic acid (R-803). Arch Int Pharmacodyn Ther 214:240–249
Szmuskovicz J, Glenn EM, Heinzelman RV, Hester JB Jr, Youngdale GA (1966) Synthesis and antiinflammatory activity of 2,3-bis (p-methoxyphenyl)indole and related compounds. J Med Chem 9:527–536
Takashima T, Kadoh Y, Kumada S (1972) Pharmacological investigations of benzothiazoline derivatives. Arzneim Forsch 22:711–715
Takesue EI, Perrine JW, Trapold JH (1976) The antiinflammatory profile of praquazone. Arch Int Pharmacodyn Ther 221:122–131
Tamura Y, Yoshimoto Y, Kunimoto K et al. (1977) Nonsteroidal antiinflammatory agents. 1. 5-Alkoxy-3-biphenylylacetic acids and related compounds as new potential antiinflammatory agents. J Med Chem 20:709–714
Tanaka K, Iizuka Y (1972) Antiinflammatory effect of bimetopyrol. I. Suppressive effect on acute inflammation. J Pharm Soc Jpn 92:1–10
Tanaka K, Iizuka Y, Yoshida N, Tomita K, Masuda H (1972) Diaryl pyrroles: a new series of antiinflammatory agents. Experientia 28:937–938
Teotino UM, Friz P, Gandini A, Bella DD (1963) Thioderivatives of 2,3-dihydro-4H -l,3-benzoxazin-4-one. Synthesis and pharmacological properties. J Med Chem 6:248–250
Testoni F, Strano A (1950) Clinical research on the treatment of acute articular rheumatism with sodium gentisate. Minerva Med 41 (II):450–456
Tricerri S, Panto E, Bianchetti A, Bossoni G, Venturini R (1979) Synthesis and preliminary pharmacological data on zidometacin, a new antiinflammatory compound. Eur J Med Chem 14:181–183
Tsukada W, Tsubokawa M, Masukawa T, Kojima H, Kasahara A (1978) Pharmacological study of 6,ll-dihydro-ll-oxodibenz[b,e]oxepin-3-acetic acid (oxepinac): a new antiinflammatory drug. Arzneim Forsch 28:428–438
Tubaro E, Banci F (1970) Pharmacology of a nicotinamidomethylaminopyrazolone (Ra 101). Arzneim Forsch 20:1019–1023
Ueno K, Kubo S, Tagawa H et al. (1976) 6,11-Dihydro-ll-oxodibenz[b,e]oxepinacetic acids with potent antiinflammatory activity. J Med Chem 19:941–946
Unterhalt B (1970) Untersuchungen an neueren Antiphlogistica. Arch Pharm (Weinheim) 303:445–456
Van Arman CG, Bohidar NR (1978) Antiarthritics. In: Rubin AA (ed) New drugs - discovery and development. (Drugs and pharmaceutical sciences, vol 5). Dekker, New York, pp 1–27
Van Arman CG, Campbell WC (1975) Anti-inflammatory activity of thiabendazole and its relation to parasitic disease. Tex Rep Biol Med 33:303–311
Van Arman CG, Risley EA, Nuss GW, Hucker HB, Duggan DE (1976) Pharmacology of sulindac. In: Huskisson EC, Franchimont P (eds) Clinoril in the treatment of rheumatic disorders. Raven, New York, pp 9–36
Van Daele PGH, Boey JM, Sipido VK, DeBruyn MFL, Janssen PAJ (1975) Synthesis of a-methyl-4-(2-thienylcarbonyl)benzeneacetic acid, suprofen, and derivatives. Arzneim Forsch 25:1495–1501
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action of aspirinlike drugs. Nature New Biol 231:232–235
Veale WL, Cooper KE (1974) Evidence for the involvement of prostaglandins in fever. In: Lederis K, Cooper KE (eds) Recent studies of hypothalamic function. Int Symp, Calgary, 1973. Karger, Basel, pp 359–370
Veale WL, Cooper KE (1975) Comparison of sites of action of PG E1 leucocyte pyrogen in brain. In: Schönbaum E, Lomax P, Jacob J (eds) Temperature regulation and drug action. Karger, Basel, pp 218–226
Vignec A J, Gasparik M (1958) Antipyretic effectiveness of salicylamide and acetylsalicylic acid in infants. A comparative study. JAMA 167:1821–1826
von Gerhardt C (1853) Untersuchungen über die wasserfreien organischen Säuren. Liebigs Ann 87:149–178
von Mering J (1893) Ueber die Function des Magens. Ther Monatsch (Berl) 7:201–204
Wada J, Suzuki T, Iwasaki M, Miyamatsu H, Ueno S, Shimizu M (1973) A new nonsteroidal antiinflammatory agent. 2-Substituted 5- or 6-benzothiazoleacetic acids and their derivatives. J Med Chem 16:930–934
Walford GL, Jones H, Shen TY (1971) Aza analogs of 5-(p-fluorophenyl) salicylic acid. J Med Chem 14:339–344
Warren MR, Warren HW (1946) The evaluation of antipyretics against pyrogen-induced fever. J Am Pharm Assoc 35:257–259
Watnick AS, Taber RI, Tabachnick IIA (1971) Anti-inflammatory and analgesic properties of clonixin [2-(2-methyl-3-chloroanilino)nicotinic acid]. Arch Int Pharmacodyn Ther 190:78–90
Weisbach JW, Kirkpatrick JL, Madso E, Douglas B (1968) Synthesis and pharmacology of some a-keto-, a-hydroxy-, and a-amino-l-benzylisoquinolines. J Med Chem 11:760–764
Westby TR, Barfknecht CF (1973) Acridan-4-carboxylic acids and 7V-aryl-2-amino-3-toluic acids as planar and antiplanar analogs of antiinflammatory N-arylanthranilic acids. J Med Chem 16:40–43
Whitehouse MW (1964) Biochemical properties of anti-inflammatory drugs. III. Uncoupling of oxidative phosphorylation in a connective tissue (cartilage) and liver mitochondria by salicylate analogues: relationship of structure to activity. Biochem Pharmacol 13:319–336
Whitehouse MW, Haslam JM (1962) Ability of some antirheumatic drugs to uncouple oxidative phosphorylation. Nature 196:1323–1324
Wiesinger D, Gubler HU, Haefliger W, Hauser D (1974) Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wartmannin and of some of its derivatives. Ex- perientia 30:135–136
Winder CV, Wax J, Scotti L, Scherrer RA, Jones EM, Short FW (1962) Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid). J Pharmacol Exp Ther 138:405–413
Winder CV, Kaump DH, Glazko AJ, Holmes EL (1967) Pharmacology of the fenamates. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. Ann Phys Med [Suppl] 7–49
Winter CA (1965) Anti-inflammatory testing method: Comparative evaluation of indomethacin and other agents. Int Congr Ser 82:190–202
Winter CA, Nuss GW (1963) Pyretogenic effects of bacterial lipopolysaccharide and the assay of antipyretic drugs in rats. Toxicol Appl Pharmacol 5:247–256
Winter CA, Risley EA, Nuss GW (1963) Anti-inflammatory and antipyretic activities of indomethacin, l-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid. J Pharmacol Exp Ther 141:369–376
Wit A, Wang SC (1968) Temperature-sensitive neurons in preoptic/anterior hypothalamic region: actions of pyrogen and acetylsalicylate. Am J Physiol 215:1160–1169
Witthauer K (1899) Aspirin, ein neues Salicylpräparat. Ther Mh 13:330 Wohlgemut J (1899) Über Aspirin (Acetylsalicylsäure). Ther Mh 13:276–278
Wong S, Gardocki JF, Pruss TP (1973) Pharmacologic evaluation of tolectin (tolmetin, McN-2559) and McN-2891, two antiinflammatory agents. J Pharmacol Exp Ther 185:127–138
Woo WS (1963) Pharmacologically active component in Scrophularia root, p-methoxycinnamic acid. I. Identification of p-methoxycinnamic acid and its antipyretic action. Yakhak Hoechi 7:55–57
Yamamoto H, Saito C, Okamoto T, Awata H, Inukai T, Hirohashi A, Yukawa Y (1969) Synthesis and pharmacology of a new potential anti-inflammatory drug, l-(3’,4’-methylenedioxybenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid (ID-955). Arzneim Forsch 19:981–984
Yamamoto H, Saito C, Inaba S, Awata H, Yamamoto M, Sakai Y, Komatsu T (1973) Novel quinazoline derivatives. II. A new antiinflammatory agent, SL-512. Arzneim Forsch 23:1266–1271
Zimmermann D (1875) Ein Beitrag zur Kenntnis der antifebrilen Wirksamkeit der Salicyl- säure. Arch Exp Pathol Pharmakol 4:248–250
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kim, D.H., Van Arman, C.G., Armstrong, D. (1982). The Chemistry of the Non-Steroidal Antipyretic Agents: Structure-Activity Relationships. In: Milton, A.S. (eds) Pyretics and Antipyretics. Handbook of Experimental Pharmacology, vol 60. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68569-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-68569-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68571-2
Online ISBN: 978-3-642-68569-9
eBook Packages: Springer Book Archive